Insulin sensitivity and beta cell function in IGT and treatment-naive patients with type 2 diabetes of different ethnicities: a pooled analysis from clinical studies

被引：0
|
作者：
Del Prato, S. [1 ]
Matthews, D. R. [2 ]
Bader, G. [3 ]
Paldanius, P. M. [4 ,5 ,6 ]
机构：
[1] Univ Pisa, Sec Diabet, Pisa, Italy
[2] Oxford Ctr Diabet, Endocrinol & Metab, Oxford, England
[3] Novartis Pharma AG, Basel, Switzerland
[4] Univ Helsinki, Childrens Hosp, Helsinki, Finland
[5] Helsinki Univ ty Hosp, Childrens Hosp, Helsinki, Finland
[6] Univ Helsinki, Res Program Clin & Mol Metab, Helsinki, Finland
来源：
DIABETOLOGIA | 2021年 / 64卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
370
引用
收藏
页码：191 / 192
页数：2
相关论文
共 50 条
  • [1] Beta-cell function in treatment-naive patients with type 2 diabetes mellitus: Analyses of baseline data from 15 clinical trials
    Blueher, Matthias
    Malhotra, Ankur
    Bader, Giovanni
    DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1403 - 1407
  • [2] PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naive type 2 diabetes mellitus patients
    Liu, Xu
    Song, Ling
    Zhang, Yuanhui
    Li, Haiyan
    Cui, Cheng
    Liu, Dongyang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [3] Dorzagliatin in combination with sitagliptin improves insulin sensitivity and beta cell function in patients with type 2 diabetes
    Zhang, Y.
    Feng, L.
    Zhang, J.
    Liu, H.
    Jiang, M.
    Chen, L.
    Liu, D.
    DIABETOLOGIA, 2024, 67 : S335 - S335
  • [4] Reduction in HbA1c and hypoglycaemia rates with insulin glargine vs NPH in treatment-naive patients with type 2 diabetes stratified by BMI: pooled analysis of 6 clinical trials
    Bolli, G. B.
    Porcellati, F.
    Lin, J.
    Cali, A.
    Wang, E.
    Dain, M. -P.
    Lucidi, P.
    Fanelli, C. G.
    DIABETOLOGIA, 2012, 55 : S385 - S385
  • [5] Relationship of oxygen consumption with beta cell function and insulin sensitivity in IGT and newly diagnosed type 2 diabetic subjects
    Nahar, Q.
    Faruque, M. O.
    Rashid, M. A.
    Rahman, M. H.
    Sultana, K.
    Kasem, S.
    Khan, A. K. Azad
    DIABETOLOGIA, 2007, 50 : S331 - S332
  • [6] Mechanistic disease progression analysis indicates that pioglitazone improves beta-cell function in treatment-naive type 2 diabetics
    De Winter, W
    Dejongh, J
    Urquhart, R
    Moules, I
    Eckland, D
    Danhof, M
    DIABETES, 2005, 54 : A65 - A65
  • [7] Beta cell loss in treatment-naive patients with type 2 diabetes based on disease duration and HbA1c levels: results from 15 clinical trials
    Blueher, M.
    Malhotra, A.
    Bader, G.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 174 - 174
  • [8] Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes
    Nolan, J. J.
    F'rch, K.
    DIABETOLOGIA, 2012, 55 (11) : 2863 - 2867
  • [9] Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes
    J. J. Nolan
    K. Færch
    Diabetologia, 2012, 55 : 2863 - 2867
  • [10] Orforglipron Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes
    Rosenstock, Julio
    Robins, Deborah A.
    Duffin, Kevin L.
    Wilson, Jonathan M.
    Mather, Kieren J.
    Banerjee, Hiya
    Lin, Yanzhu
    Eyde, Sarah
    Kazda, Christof M.
    Konig, Manige
    DIABETES, 2024, 73
12345